In clinical trials in adult patients for weight reduction, cholelithiasis was reported by 1.6% of Wegovy injection-treated patients and 0.7% of placebo patients
The injection is daily at bedtime on an empty stomach
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
When youre eating less, losing weight quickly or recovering from a period of physical stress, your body directs energy and nutrients towards vital organs and processes first
If needed, treatment can be adjusted
The stability sweet spot Research on peptide stability suggests that moderate concentrations, typically in the 1-10 mg/mL range, offer the best balance between stability and practicality